Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-14

Clinical Trial Update: Duloxetine Role in Reducing Opioid Consumption After Thoracotomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating duloxetine for reducing opioid consumption after thoracotomy in patients with post-thoracotomy pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Assiut University | Conditions: Post-thoracotomy Pain | Phase 4 | Status: COMPLETED